TARP and gastric cancer: PD-L1 expression has been observed in a variety of solid tumors including gastric cancer [26,27], which engages programmed cell death-1 (PD-1) on T cells and subsequently triggers inhibitory signaling downstream of the T-cell antigen receptors, reducing T-cell killing capacity [28].